Globe Newswire (Tue, 17-Feb 4:33 PM ET)
PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit
PRNewswire (Tue, 17-Feb 3:00 PM ET)
Globe Newswire (Tue, 17-Feb 1:22 PM ET)
Business Wire (Tue, 17-Feb 10:00 AM ET)
Newsfile (Mon, 16-Feb 5:30 PM ET)
Globe Newswire (Mon, 16-Feb 10:15 AM ET)
Globe Newswire (Sat, 14-Feb 7:17 AM ET)
Globe Newswire (Fri, 13-Feb 3:44 PM ET)
Globe Newswire (Fri, 13-Feb 2:26 PM ET)
Globe Newswire (Fri, 13-Feb 12:24 PM ET)
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.
Picard Medical trades on the AMEX stock market under the symbol PMI.
As of February 17, 2026, PMI stock price declined to $1.45 with 547,554 million shares trading.
PMI has a beta of -1.50, meaning it tends to be less sensitive to market movements. PMI has a correlation of 0.01 to the broad based SPY ETF.
PMI has a market cap of $106.87 million. This is considered a Micro Cap stock.
The top ETF exchange traded funds that PMI belongs to (by Net Assets): VTWO, IWC, RSSL, UWM, URTY.
PMI support price is $1.43 and resistance is $1.69 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PMI shares will trade within this expected range on the day.
